1991
DOI: 10.1097/00007890-199105000-00033
|View full text |Cite
|
Sign up to set email alerts
|

A Short Human and Mouse MLR Assay Utilizing Lymphokine (Il-2, Il-3) Secretion as an Early Activation Event

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

1992
1992
2009
2009

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Earlier diagnosis (within 72 h) may also be possible, by analysis of aniigenspecifie proliferation or cylokine production. The latter has already found clinical application in transplantation immunology, with the rapid interpretation of results of the mixed lymphocyte reaction [24].…”
Section: Discussionmentioning
confidence: 99%
“…Earlier diagnosis (within 72 h) may also be possible, by analysis of aniigenspecifie proliferation or cylokine production. The latter has already found clinical application in transplantation immunology, with the rapid interpretation of results of the mixed lymphocyte reaction [24].…”
Section: Discussionmentioning
confidence: 99%
“…The colorimetric MTT technique [15] was employed for this purpose. Single splenocyte suspensions were used.…”
Section: One Way Mlrmentioning
confidence: 99%
“…Liposomes were separated from the nonencapsulated protein by centrifugation, and encapsulation efficiency was determined by bioassay for IL-2 [Bishara et al, 1991;Kedar et al, 1994] and by protein assay for HN by Peterson's modification [Peterson, 1983] of the method of Lowry et al [1951]. Encapsulation was !80% for IL-2 and 60-80%, depending on the viral strain, for HN.…”
Section: Liposomal Vaccine (Influsome-vac)mentioning
confidence: 99%
“…Neutralizing anti-IL-2 antibodies were assessed by bioassay, using the IL-2-dependent murine T-cell line CTLL-2 [Bishara et al, 1991;Kedar et al, 1994]. Briefly, recombinant human IL-2 (50 ml, 2 ng/ml, Chiron, Emeryville, CA) was mixed with 50 ml of heatinactivated sera from vaccinees, diluted 1:2-1:256 in 96-well flat-bottomed microtiter plates, and incubated at 378C for 1 hr.…”
Section: Assaysmentioning
confidence: 99%